Juniper appointed partner for groundbreaking cancer drug delivery platform

3 years ago

Nottingham, UK – Juniper Pharma Services, a subsidiary of Juniper Pharmaceuticals, Inc. (Nasdaq: JNP), has entered into a long-term collaboration with OxSonics Limited (“OxSonics”) to support the development, scale-up, and GMP manufacturing of OxSonics’ proprietary “sono-sensitive particles.” The collaboration will see the contract development and manufacturing organisation (CDMO) support the Oxford-based company develop these injectable particles, which when used in conjunction